Intrasense and MeVis Medical Solutions AG specialized in
the development of clinical applications integrating artificial intelligence, announce a global partnership in the field of lung diseases.

Intrasense announces the publication of its half year liquidity contract signed with TSAF – Tradition Securities And Futures.

Intrasense strengthens its management team with the appointment of Khalil Filali as Group Chief Business Officer.

Intrasense™ announces the end of the BCS (Bond Convertible into Shares) financing contract concluded with the Luxembourgish fund European High Growth Opportunities Securitization Fund (EHGO).

Intrasense announces the appointment of Lionel Seltz as Group Chief Financial Officer. Financial expertise and international background in structuring growing companies to meet the new corporate development requirements.

Intrasense is pleased to present the new version 2.8 of its visualization platform with many new features, from clinical applications to improved workflow.

Intrasense announces following a Board meeting on October 8th, 2020, a partial renewal and strengthening of its composition. Michèle Lesieur is coopted as administrator and appointed Chairman of the Board. Anne Larpin is coopted as administrator of the company. The ratification of these cooptations will be submitted to the next ordinary general meeting.

Intrasense announces its 2020 consolidated IFRS half-year results at Group level as of June 30, 2020.

Intrasense announces that the scanner reading protocol dedicated to COVID-19 has obtained its CE marking as a world premiere.

Intrasense continues its involvement in the fight against COVID-19 and announces the availability on Friday April 17th, 2020 of a second version of its scanner reading protocol dedicated to the epidemic.